Brainsway Ltd. - American Depositary Shares (BWAY) closed at $10.67 on November 10, 2026, down 8.3% from the previous close, on volume of 490,444 shares (30-day average 101,637).
Data as of November 10, 2026.
10-Nov-2026
BrainsWay Investor Deck Details Q3 2026 Growth and Scale
TipRanks (Tue, 10-Nov 4:34 PM ET)
BrainsWay GAAP EPS of $0.05 misses by $0.04, revenue of $18.15M beats by $0.35M
Seeking Alpha News (Tue, 10-Nov 8:03 AM ET)
BrainsWay Reports 34% Third-Quarter Revenue Growth to $18.1 Million
TipRanks (Tue, 10-Nov 7:57 AM ET)
BrainsWay Reports Third Quarter 2026 Financial Results and Operational Highlights
Globe Newswire (Tue, 10-Nov 7:30 AM ET)
Here are the major earnings before the open Tuesday
Seeking Alpha News (Mon, 9-Nov 6:00 PM ET)
BrainsWay Q3 2026 Earnings Preview
Seeking Alpha News (Mon, 9-Nov 9:34 AM ET)
BrainsWay Announces Strategic Collaboration with Mindful Health Solutions
Globe Newswire (Mon, 2-Nov 7:30 AM ET)
BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026
Globe Newswire (Wed, 28-Oct 8:00 AM ET)
BrainsWay Expands U.S. Insurance Coverage for Deep TMS Treatment of OCD to Over 118 Million Lives
Globe Newswire (Mon, 26-Oct 7:30 AM ET)
Market Chameleon (Mon, 19-Oct 7:49 AM ET)
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Brainsway Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol BWAY.
As of November 10, 2026, BWAY stock price declined to $10.67 with 490,444 million shares trading.
BWAY has a beta of 0.84, meaning it tends to be less sensitive to market movements. BWAY has a correlation of 0.01 to the broad based SPY ETF.
BWAY has a market cap of $429.37 million. This is considered a Small Cap stock.
Last quarter Brainsway Ltd. - American Depositary Shares reported $17 million in Revenue and $.07 earnings per share. This beat revenue expectation by $610,200 and missed earnings estimates by -$.01.
In the last 3 years, BWAY traded as high as $17.40 and as low as $.95.
The top ETF exchange traded funds that BWAY belongs to (by Net Assets): IZRL, ITEQ, APIE, EHLS, IBRN.
BWAY has outperformed the market in the last year with a return of +173.8%, while the SPY ETF gained +12.9%. However, in the most recent history, BWAY shares have underperformed the stock market with its stock returning -31.2% in the last 3 month period and -4.8% for the last 2 week period, while SPY has returned -2.8% and -2.0%, respectively.
BWAY support price is $11.15 and resistance is $12.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BWAY shares will trade within this expected range on the day.
